Invitris
Invitris is a protein-based drugs founded in 2022 by Patrick Grossmann.
Accelerator
Country
Founded Date
2022
0
Founder
Headquarters
Accelerator Batch
Industry
Investors
Latest Funding Round Date
April 5, 2023
Latest Funding Round Amount (USD)
500,000
Latest Funding Type
LinkedIn URL
Location
Number of Employees
6
0
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
1,000,000
Official Website
Y Combinator URL
Find more companies like Invitris
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.